<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
  <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
  <meta http-equiv="Content-Style-Type" content="text/css" />
  <meta name="generator" content="pandoc" />
  <title></title>
  <style type="text/css">code{white-space: pre;}</style>
</head>
<body>
<h3 id="mondo0018882"><a href="http://purl.obolibrary.org/obo/MONDO_0018882">MONDO:0018882</a></h3>
<p><strong>Label:</strong> vasculitis</p>
<p><strong>Subclasses:</strong> <a href="http://purl.obolibrary.org/obo/MONDO_0015488">MONDO:0015488</a> (predominantly large-vessel vasculitis), <a href="http://purl.obolibrary.org/obo/MONDO_0019170">MONDO:0019170</a> (polyarteritis nodosa), <a href="http://purl.obolibrary.org/obo/MONDO_0015489">MONDO:0015489</a> (predominantly medium-vessel vasculitis), <a href="http://purl.obolibrary.org/obo/MONDO_0018640">MONDO:0018640</a> (secondary vasculitis), <a href="http://purl.obolibrary.org/obo/MONDO_0017991">MONDO:0017991</a> (Takayasu arteritis), <a href="http://purl.obolibrary.org/obo/MONDO_0015491">MONDO:0015491</a> (immune complex mediated vasculitis), <a href="http://purl.obolibrary.org/obo/MONDO_0015490">MONDO:0015490</a> (predominantly small-vessel vasculitis), <a href="http://purl.obolibrary.org/obo/MONDO_0015492">MONDO:0015492</a> (Anti-neutrophil cytoplasmic antibody-associated vasculitis), <a href="http://purl.obolibrary.org/obo/MONDO_0018593">MONDO:0018593</a> (primary polyarteritis nodosa), <a href="http://purl.obolibrary.org/obo/MONDO_0007407">MONDO:0007407</a> (Cryoglobulinemic vasculitis), <a href="http://purl.obolibrary.org/obo/MONDO_0014306">MONDO:0014306</a> (vasculitis due to ADA2 deficiency),</p>
<p><strong>Corr. equiv. classes:</strong> <a href="http://www.orpha.net/ORDO/Orphanet_445197">Orphanet:445197</a>, <a href="http://www.orpha.net/ORDO/Orphanet_156149">Orphanet:156149</a>, <a href="http://www.orpha.net/ORDO/Orphanet_156146">Orphanet:156146</a>, <a href="http://www.orpha.net/ORDO/Orphanet_156152">Orphanet:156152</a>, <a href="http://www.orpha.net/ORDO/Orphanet_156143">Orphanet:156143</a>, <a href="http://purl.obolibrary.org/obo/OMIM_123550">OMIM:123550</a>, <a href="http://www.orpha.net/ORDO/Orphanet_156140">Orphanet:156140</a>, <a href="http://www.orpha.net/ORDO/Orphanet_91138">Orphanet:91138</a>, <a href="http://www.orpha.net/ORDO/Orphanet_439737">Orphanet:439737</a>, <a href="http://purl.obolibrary.org/obo/OMIM_615688">OMIM:615688</a>, <a href="http://purl.obolibrary.org/obo/OMIM_207600">OMIM:207600</a>, <a href="http://www.orpha.net/ORDO/Orphanet_767">Orphanet:767</a>, <a href="http://www.orpha.net/ORDO/Orphanet_3287">Orphanet:3287</a>, <a href="http://www.orpha.net/ORDO/Orphanet_404553">Orphanet:404553</a>,</p>
<p><strong>Class expressions from DL-Learner:</strong></p>
<ul>
<li><a href="http://purl.obolibrary.org/obo/HP_0002715">HP:0002715</a> (Abnormality of the immune system) and <a href="http://purl.obolibrary.org/obo/HP_0011025">HP:0011025</a> (Abnormality of cardiovascular system physiology) 22.32%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001871">HP:0001871</a> (Abnormality of blood and blood-forming tissues) and <a href="http://purl.obolibrary.org/obo/HP_0011025">HP:0011025</a> (Abnormality of cardiovascular system physiology) 21.60%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001626">HP:0001626</a> (Abnormality of the cardiovascular system) 21.30%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001939">HP:0001939</a> (Abnormality of metabolism/homeostasis) and <a href="http://purl.obolibrary.org/obo/HP_0011025">HP:0011025</a> (Abnormality of cardiovascular system physiology) 20.73%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0025015">HP:0025015</a> (Abnormal vascular morphology) 20.08%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000118">HP:0000118</a> (Phenotypic abnormality) 19.70%</li>
<li>Thing 19.69%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000001">HP:0000001</a> (All) 19.69%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0011025">HP:0011025</a> (Abnormality of cardiovascular system physiology) 18.87%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0010978">HP:0010978</a> (Abnormality of immune system physiology) 18.53%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002597">HP:0002597</a> (Abnormality of the vasculature) 18.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001871">HP:0001871</a> (Abnormality of blood and blood-forming tissues) 18.40%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0030680">HP:0030680</a> (Abnormality of cardiovascular system morphology) 18.21%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002715">HP:0002715</a> (Abnormality of the immune system) 17.94%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001939">HP:0001939</a> (Abnormality of metabolism/homeostasis) 17.27%</li>
</ul>
</body>
</html>
